Request for Covid-19 Impact Assessment of this Report
The United States Small Molecule Targeted Anti-cancer Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Small Molecule Targeted Anti-cancer Drug market, reaching US$ million by the year 2028. As for the Europe Small Molecule Targeted Anti-cancer Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Small Molecule Targeted Anti-cancer Drug players cover Astrazeneca, Novartis, Millennium Pharmaceuticals, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Targeted Anti-cancer Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
EGFR
ALK
Bcr-Abl
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Targeted Anti-cancer Drug Market Size 2017-2028
2.1.2 Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Small Molecule Targeted Anti-cancer Drug Segment by Type
2.2.1 EGFR
2.2.2 ALK
2.2.3 Bcr-Abl
2.2.4 Others
2.3 Small Molecule Targeted Anti-cancer Drug Market Size by Type
2.3.1 Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
2.4 Small Molecule Targeted Anti-cancer Drug Segment by Application
2.4.1 Liver Cancer
2.4.2 Colorectal Cancer
2.4.3 Lung Cancer
2.4.4 Gastric Cancer
2.4.5 Breast Cancer
2.4.6 Esophageal Cancer
2.4.7 Others
2.5 Small Molecule Targeted Anti-cancer Drug Market Size by Application
2.5.1 Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
3 Small Molecule Targeted Anti-cancer Drug Market Size by Player
3.1 Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Players
3.1.1 Global Small Molecule Targeted Anti-cancer Drug Revenue by Players (2020-2022)
3.1.2 Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Players (2020-2022)
3.2 Global Small Molecule Targeted Anti-cancer Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Targeted Anti-cancer Drug by Regions
4.1 Small Molecule Targeted Anti-cancer Drug Market Size by Regions (2017-2022)
4.2 Americas Small Molecule Targeted Anti-cancer Drug Market Size Growth (2017-2022)
4.3 APAC Small Molecule Targeted Anti-cancer Drug Market Size Growth (2017-2022)
4.4 Europe Small Molecule Targeted Anti-cancer Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Small Molecule Targeted Anti-cancer Drug Market Size by Country (2017-2022)
5.2 Americas Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022)
5.3 Americas Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Targeted Anti-cancer Drug Market Size by Region (2017-2022)
6.2 APAC Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022)
6.3 APAC Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Targeted Anti-cancer Drug by Country (2017-2022)
7.2 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022)
7.3 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Targeted Anti-cancer Drug by Region (2017-2022)
8.2 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule Targeted Anti-cancer Drug Market Forecast
10.1 Global Small Molecule Targeted Anti-cancer Drug Forecast by Regions (2023-2028)
10.1.1 Global Small Molecule Targeted Anti-cancer Drug Forecast by Regions (2023-2028)
10.1.2 Americas Small Molecule Targeted Anti-cancer Drug Forecast
10.1.3 APAC Small Molecule Targeted Anti-cancer Drug Forecast
10.1.4 Europe Small Molecule Targeted Anti-cancer Drug Forecast
10.1.5 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Forecast
10.2 Americas Small Molecule Targeted Anti-cancer Drug Forecast by Country (2023-2028)
10.2.1 United States Small Molecule Targeted Anti-cancer Drug Market Forecast
10.2.2 Canada Small Molecule Targeted Anti-cancer Drug Market Forecast
10.2.3 Mexico Small Molecule Targeted Anti-cancer Drug Market Forecast
10.2.4 Brazil Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3 APAC Small Molecule Targeted Anti-cancer Drug Forecast by Region (2023-2028)
10.3.1 China Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3.2 Japan Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3.3 Korea Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3.4 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3.5 India Small Molecule Targeted Anti-cancer Drug Market Forecast
10.3.6 Australia Small Molecule Targeted Anti-cancer Drug Market Forecast
10.4 Europe Small Molecule Targeted Anti-cancer Drug Forecast by Country (2023-2028)
10.4.1 Germany Small Molecule Targeted Anti-cancer Drug Market Forecast
10.4.2 France Small Molecule Targeted Anti-cancer Drug Market Forecast
10.4.3 UK Small Molecule Targeted Anti-cancer Drug Market Forecast
10.4.4 Italy Small Molecule Targeted Anti-cancer Drug Market Forecast
10.4.5 Russia Small Molecule Targeted Anti-cancer Drug Market Forecast
10.5 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Forecast by Region (2023-2028)
10.5.1 Egypt Small Molecule Targeted Anti-cancer Drug Market Forecast
10.5.2 South Africa Small Molecule Targeted Anti-cancer Drug Market Forecast
10.5.3 Israel Small Molecule Targeted Anti-cancer Drug Market Forecast
10.5.4 Turkey Small Molecule Targeted Anti-cancer Drug Market Forecast
10.5.5 GCC Countries Small Molecule Targeted Anti-cancer Drug Market Forecast
10.6 Global Small Molecule Targeted Anti-cancer Drug Forecast by Type (2023-2028)
10.7 Global Small Molecule Targeted Anti-cancer Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Astrazeneca
11.1.1 Astrazeneca Company Information
11.1.2 Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Offered
11.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Astrazeneca Main Business Overview
11.1.5 Astrazeneca Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Small Molecule Targeted Anti-cancer Drug Product Offered
11.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Information
11.3.2 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Offered
11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Millennium Pharmaceuticals Main Business Overview
11.3.5 Millennium Pharmaceuticals Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Small Molecule Targeted Anti-cancer Drug Product Offered
11.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Exelixis
11.5.1 Exelixis Company Information
11.5.2 Exelixis Small Molecule Targeted Anti-cancer Drug Product Offered
11.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Exelixis Main Business Overview
11.5.5 Exelixis Latest Developments
11.6 Abbvie
11.6.1 Abbvie Company Information
11.6.2 Abbvie Small Molecule Targeted Anti-cancer Drug Product Offered
11.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Abbvie Main Business Overview
11.6.5 Abbvie Latest Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Information
11.7.2 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Offered
11.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Boehringer-Ingelheim Main Business Overview
11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Eisai
11.8.1 Eisai Company Information
11.8.2 Eisai Small Molecule Targeted Anti-cancer Drug Product Offered
11.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Eisai Main Business Overview
11.8.5 Eisai Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Small Molecule Targeted Anti-cancer Drug Product Offered
11.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Offered
11.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Bristol-Myers Squibb Main Business Overview
11.10.5 Bristol-Myers Squibb Latest Developments
11.11 Roche
11.11.1 Roche Company Information
11.11.2 Roche Small Molecule Targeted Anti-cancer Drug Product Offered
11.11.3 Roche Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Roche Main Business Overview
11.11.5 Roche Latest Developments
11.12 Bettapharma
11.12.1 Bettapharma Company Information
11.12.2 Bettapharma Small Molecule Targeted Anti-cancer Drug Product Offered
11.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bettapharma Main Business Overview
11.12.5 Bettapharma Latest Developments
12 Research Findings and Conclusion
Table 1. Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of EGFR
Table 3. Major Players of ALK
Table 4. Major Players of Bcr-Abl
Table 5. Major Players of Others
Table 6. Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
Table 9. Small Molecule Targeted Anti-cancer Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
Table 12. Global Small Molecule Targeted Anti-cancer Drug Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Player (2020-2022)
Table 14. Small Molecule Targeted Anti-cancer Drug Key Players Head office and Products Offered
Table 15. Small Molecule Targeted Anti-cancer Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Molecule Targeted Anti-cancer Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Regions (2017-2022)
Table 20. Americas Small Molecule Targeted Anti-cancer Drug Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Country (2017-2022)
Table 22. Americas Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
Table 24. Americas Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
Table 26. APAC Small Molecule Targeted Anti-cancer Drug Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Region (2017-2022)
Table 28. APAC Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
Table 30. APAC Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
Table 32. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Country (2017-2022)
Table 34. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
Table 36. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Small Molecule Targeted Anti-cancer Drug
Table 45. Key Market Challenges & Risks of Small Molecule Targeted Anti-cancer Drug
Table 46. Key Industry Trends of Small Molecule Targeted Anti-cancer Drug
Table 47. Global Small Molecule Targeted Anti-cancer Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Small Molecule Targeted Anti-cancer Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Small Molecule Targeted Anti-cancer Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share Forecast by Application (2023-2028)
Table 53. Astrazeneca Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 54. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Offered
Table 55. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Astrazeneca Main Business
Table 57. Astrazeneca Latest Developments
Table 58. Novartis Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 59. Novartis Small Molecule Targeted Anti-cancer Drug Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis Latest Developments
Table 63. Millennium Pharmaceuticals Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 64. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Offered
Table 65. Millennium Pharmaceuticals Main Business
Table 66. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Millennium Pharmaceuticals Latest Developments
Table 68. Bayer Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 69. Bayer Small Molecule Targeted Anti-cancer Drug Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Bayer Latest Developments
Table 73. Exelixis Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 74. Exelixis Small Molecule Targeted Anti-cancer Drug Product Offered
Table 75. Exelixis Main Business
Table 76. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Exelixis Latest Developments
Table 78. Abbvie Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 79. Abbvie Small Molecule Targeted Anti-cancer Drug Product Offered
Table 80. Abbvie Main Business
Table 81. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Abbvie Latest Developments
Table 83. Boehringer-Ingelheim Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 84. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Offered
Table 85. Boehringer-Ingelheim Main Business
Table 86. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Boehringer-Ingelheim Latest Developments
Table 88. Eisai Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 89. Eisai Small Molecule Targeted Anti-cancer Drug Product Offered
Table 90. Eisai Main Business
Table 91. Eisai Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Eisai Latest Developments
Table 93. Pfizer Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 94. Pfizer Small Molecule Targeted Anti-cancer Drug Product Offered
Table 95. Pfizer Main Business
Table 96. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Pfizer Latest Developments
Table 98. Bristol-Myers Squibb Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 99. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Offered
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Bristol-Myers Squibb Latest Developments
Table 103. Roche Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 104. Roche Small Molecule Targeted Anti-cancer Drug Product Offered
Table 105. Roche Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Bettapharma Details, Company Type, Small Molecule Targeted Anti-cancer Drug Area Served and Its Competitors
Table 109. Bettapharma Small Molecule Targeted Anti-cancer Drug Product Offered
Table 110. Bettapharma Main Business
Table 111. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Bettapharma Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Anti-cancer Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type in 2021
Figure 7. Small Molecule Targeted Anti-cancer Drug in Liver Cancer
Figure 8. Global Small Molecule Targeted Anti-cancer Drug Market: Liver Cancer (2017-2022) & ($ Millions)
Figure 9. Small Molecule Targeted Anti-cancer Drug in Colorectal Cancer
Figure 10. Global Small Molecule Targeted Anti-cancer Drug Market: Colorectal Cancer (2017-2022) & ($ Millions)
Figure 11. Small Molecule Targeted Anti-cancer Drug in Lung Cancer
Figure 12. Global Small Molecule Targeted Anti-cancer Drug Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 13. Small Molecule Targeted Anti-cancer Drug in Gastric Cancer
Figure 14. Global Small Molecule Targeted Anti-cancer Drug Market: Gastric Cancer (2017-2022) & ($ Millions)
Figure 15. Small Molecule Targeted Anti-cancer Drug in Breast Cancer
Figure 16. Global Small Molecule Targeted Anti-cancer Drug Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 17. Small Molecule Targeted Anti-cancer Drug in Esophageal Cancer
Figure 18. Global Small Molecule Targeted Anti-cancer Drug Market: Esophageal Cancer (2017-2022) & ($ Millions)
Figure 19. Small Molecule Targeted Anti-cancer Drug in Others
Figure 20. Global Small Molecule Targeted Anti-cancer Drug Market: Others (2017-2022) & ($ Millions)
Figure 21. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application in 2021
Figure 22. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Player in 2021
Figure 23. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Small Molecule Targeted Anti-cancer Drug Market Size 2017-2022 ($ Millions)
Figure 25. APAC Small Molecule Targeted Anti-cancer Drug Market Size 2017-2022 ($ Millions)
Figure 26. Europe Small Molecule Targeted Anti-cancer Drug Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size 2017-2022 ($ Millions)
Figure 28. Americas Small Molecule Targeted Anti-cancer Drug Value Market Share by Country in 2021
Figure 29. Americas Small Molecule Targeted Anti-cancer Drug Consumption Market Share by Type in 2021
Figure 30. Americas Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application in 2021
Figure 31. United States Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Region in 2021
Figure 36. APAC Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application in 2021
Figure 37. China Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Country in 2021
Figure 44. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type in 2021
Figure 45. Europe Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application in 2021
Figure 46. Germany Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Application in 2021
Figure 54. Egypt Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Small Molecule Targeted Anti-cancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 60. APAC Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 61. Europe Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 63. United States Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 64. Canada Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 67. China Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 68. Japan Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 69. Korea Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 71. India Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 72. Australia Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 73. Germany Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 74. France Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 75. UK Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 76. Italy Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 77. Russia Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 78. Spain Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 81. Israel Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Small Molecule Targeted Anti-cancer Drug Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...